Product Information
COLESEVELAM HCL 3.75 G PACKET is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $3.1869 per EA under NDC 00115186418. Its NADAC has been published 87 times since Jul 5, 2023.
FDA first approved this application on Jan 18, 2023.
Strength
3.75 g/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115186418
Classification
Generic
Dosage Form
FOR SUSPENSION
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
COLESEVELAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212886FDA Approved
1/18/2023
On Market Since
1/20/2023
Pharmacological Classes
Price Statistics
The NADAC for COLESEVELAM HCL 3.75 G PACKET has been published 87 times since Jul 5, 2023, and over the history we have for it it has declined 5.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.1869 per EA |
|---|---|
| All-time high | $3.8632 (Dec 13, 2023) |
| All-time low | $2.8969 (May 22, 2024) |
| Median price | $3.1760 |
| Average price | $3.3667 |
| Largest weekly change | +18.5% (Oct 18, 2023) |
| Weeks tracked | 87 |
| Tracking since | Jul 5, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-2.2%
5Y
N/A
All
-5.5%
Last surveyed Feb 26, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Colesevelam hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Colesevelam hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bile Acid Sequestrant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of COLESEVELAM HCL 3.75 G PACKET?
The current National Average Drug Acquisition Cost (NADAC) for COLESEVELAM HCL 3.75 G PACKET, manufactured by Amneal Pharmaceuticals of New York LLC, is $3.1869 per EA (NDC 00115186418), effective Feb 26, 2025.
How has the price of COLESEVELAM HCL 3.75 G PACKET changed over time?
Over the history we have for it, the NADAC for COLESEVELAM HCL 3.75 G PACKET has declined 5.5%. It has been tracked across 87 weekly CMS publications since Jul 5, 2023.
What are the highest and lowest recorded NADAC prices for COLESEVELAM HCL 3.75 G PACKET?
Since Jul 5, 2023, the NADAC for COLESEVELAM HCL 3.75 G PACKET has ranged from a low of $2.8969 (May 22, 2024) to a high of $3.8632 (Dec 13, 2023), with a median of $3.1760 per EA.
Are there cheaper alternatives to COLESEVELAM HCL 3.75 G PACKET?
No other NADAC-published product currently shares the active ingredient and strength of COLESEVELAM HCL 3.75 G PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures COLESEVELAM HCL 3.75 G PACKET?
COLESEVELAM HCL 3.75 G PACKET (NDC 00115186418) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.